- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, March 3, 2017
Coverage of our peer-reviewed research in the healthcare and mainstream press.
The National Pharmaceutical Council’s daily newsletter on Monday highlighted a video interview posted by The American Journal of Managed Care® (AJMC®). The interview with Jonathan Hirsch, founder and president of Syapse, focused on the use of precision medicine in value-based oncology. “We really think that precision medicine is the future of cancer care, and we look forward to democratizing access for many health systems,” said Hirsch.
An article published this week in the Journal of Health Care for the Poor and Underserved about specialty care access within the safety net cited an AJMC® study, “Increasing Access to Specialty Care: Patient Discharges From a Gastroenterology Clinic.” In that study, researchers from San Francisco General Hospital found that discharging patients from specialty care to primary care for follow-up effectively improved access to specialty care for safety net patients.
This week, Rheumatology International published a review of the function of myeloid dendritic cells in rheumatoid arthritis (RA). The review referenced an article that was published by AJMC® in a supplement about RA. The article, titled “Overview of Epidemiology, Pathophysiology, and Diagnosis of Rheumatoid Arthritis,” was written by Allan Gibofsky, MD, who recently took part in a series of AJMC® video interviews, including one where he discussed the need for individualized treatments in RA.
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
